I.G. Investment Management’s GenMark Diagnostics, Inc GNMK Stock Holding History

I.G. Investment Management’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-141,280	Closed	-$1.23M	–	943
2016 Q2	$1.23M	Buy	141,280 +1,000	+0.7%	+$6.86K	﹤0.01%	609
2016 Q1	$739K	Buy	140,280 +5,691	+4%	+$31.7K	﹤0.01%	704
2015 Q4	$1.04M	Buy	134,589 +978	+0.7%	+$7.51K	﹤0.01%	627
2015 Q3	$1.05M	Buy	133,611 +811	+0.6%	+$7.5K	﹤0.01%	608
2015 Q2	$1.2M	Hold	132,800	–	–	﹤0.01%	600
2015 Q1	$1.72M	Sell	132,800 -12,537	-9%	-$164K	0.01%	531
2014 Q4	$1.98M	Sell	145,337 -9,300	-6%	-$104K	0.01%	501
2014 Q3	$1.39M	Buy	154,637 +28,100	+22%	+$302K	0.01%	526
2014 Q2	$1.71M	Buy	126,537 +53,290	+73%	+$556K	0.01%	504
2014 Q1	$728K	Sell	73,247 -7,500	-9%	-$93.2K	﹤0.01%	647
2013 Q4	$1.07M	Hold	80,747	–	–	﹤0.01%	560
2013 Q3	$981K	Buy	80,747 +11,857	+17%	+$127K	﹤0.01%	575
2013 Q2	$712K	Buy	+68,890	New	+$950K	﹤0.01%	625

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

I.G. Investment Management's GNMK Position: Q3 2016 in Review

I.G. Investment Management sold out of GenMark Diagnostics, Inc (GNMK) in Q3 2016, closing a stake of 141,280 shares — an estimated $1.23M sold.

I.G. Investment Management first reported a position in GNMK in Q2 2013 and held it in 13 quarters. The position peaked at $1.98M in Q4 2014. 91 funds tracked by Wall St. Rank hold GNMK as of Q3 2016.

I.G. Investment Management reported no remaining GenMark Diagnostics, Inc position as of Q3 2016 after selling out during the quarter.
I.G. Investment Management sold 141,280 GenMark Diagnostics, Inc shares in Q3 2016, an estimated $1.23M.
I.G. Investment Management first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 13 quarters.
I.G. Investment Management's GenMark Diagnostics, Inc position peaked at $1.98M in Q4 2014.
91 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q3 2016.

Based on I.G. Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.